[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Petillo et al., 2020 - Google Patents

Extracellular citrate is a trojan horse for cancer cells

Petillo et al., 2020

View HTML
Document ID
1140484143434059565
Author
Petillo A
Abruzzese V
Koshal P
Ostuni A
Bisaccia F
Publication year
Publication venue
Frontiers in Molecular Biosciences

External Links

Snippet

The first intermediate in the mitochondrial tricarboxylic acid (TCA) cycle is citrate, which is essential and acts as a metabolic regulator for glycolysis, TCA cycle, gluconeogenesis, and fatty acid synthesis. Within the cytosol, citrate is cleaved by ATP citrate lyase (ACLY) into …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin

Similar Documents

Publication Publication Date Title
Petillo et al. Extracellular citrate is a trojan horse for cancer cells
Wu et al. The multifaceted regulation of mitochondria in ferroptosis
Zheng et al. Synthesis of a FTO inhibitor with anticonvulsant activity
Battaglia et al. Ferroptosis and cancer: mitochondria meet the “iron maiden” cell death
Chen et al. Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer
Eltayeb et al. Reprogramming of lipid metabolism in lung cancer: an overview with focus on EGFR-mutated non-small cell lung cancer
Jia et al. ACSL4-mediated ferroptosis and its potential role in central nervous system diseases and injuries
Hu et al. Progress in understanding ferroptosis and its targeting for therapeutic benefits in traumatic brain and spinal cord injuries
Patra et al. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer
Duarte-Hospital et al. Mitochondrial dysfunction as a hallmark of environmental injury
Diaz Escarcega et al. The functional role of sphingosine kinase 2
Panieri et al. NRF2 and mitochondrial function in cancer and cancer stem cells
Tian et al. 5-Aminolevulinic acid-mediated sonodynamic therapy inhibits RIPK1/RIPK3-dependent necroptosis in THP-1-derived foam cells
Zhang et al. Maresin1 suppresses high-glucose-induced ferroptosis in osteoblasts via NRF2 activation in type 2 diabetic osteoporosis
Čater et al. Protective role of mitochondrial uncoupling proteins against age-related oxidative stress in type 2 diabetes mellitus
Fu et al. Role of mitochondria in the regulation of ferroptosis and disease
Zhang et al. Ferroptosis and musculoskeletal diseases:“Iron Maiden” cell death may be a promising therapeutic target
Cairns et al. Mitophagy: A new player in stem cell biology
Lee et al. Unleashing ferroptosis in human cancers: targeting ferroptosis suppressor protein 1 for overcoming therapy resistance
Ruiz-Pérez et al. Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma
Olga et al. The functions of mitochondrial 2′, 3′-cyclic nucleotide-3′-phosphodiesterase and prospects for its future
Clementino et al. Constitutive activation of NAD-dependent sirtuin 3 plays an important role in tumorigenesis of chromium (VI)-transformed cells
Xu et al. ELOVL5-mediated long chain fatty acid elongation contributes to enzalutamide resistance of prostate cancer
Attachaipanich et al. Potential roles of melatonin in doxorubicin-induced cardiotoxicity: from cellular mechanisms to clinical application
Podyacheva et al. Nicotinamide riboside for the prevention and treatment of doxorubicin cardiomyopathy. Opportunities and prospects